Containing Or Obtained From Citrus (e.g., Orange, Lemon, Lime, Grapefruit, Etc.) Patents (Class 424/736)
-
Publication number: 20090186105Abstract: A device and composition for delivering menthol, camphor, eucalyptus essential oils, and other essential oils with balsamic benefits, to be used for the relief of symptoms of common cold.Type: ApplicationFiled: January 23, 2009Publication date: July 23, 2009Applicant: APR Applied Pharma Research S.A.Inventors: Alberto Reiner, Giorgio Reiner
-
Publication number: 20090180971Abstract: The invention provides a method for the prevention and/or activation of defense mechanisms in the human body against conditions, disorders or diseases relating to the presence of free radicals, such as; environmental pollution, aging or smoking by rising the administration to a mammal, namely a human being, of an effective amount of a phytonutrient-and-citric-based edible dosage, during or after tobacco consumption and which is intended to prevent pathologies, conditions, disorders or diseases relating to the presence of free radicals in the human body. Likewise, the therapeutic method of the invention enables activation of defense mechanisms in the human body to reduce conditions, disorders or diseases relating to the presence of free radicals in the body.Type: ApplicationFiled: January 13, 2008Publication date: July 16, 2009Inventor: German Alfredo Martinez Marcos
-
Publication number: 20090175806Abstract: The present invention relates to a preservative or antimicrobial compositions with broad spectrum antimicrobial activity comprising low concentrations of essential oil (and/or one or more component thereof) and a botanical extract in synergistic combination with a fruit acid and alkanediol, and optionally a solvent. The compositions of the invention may be used in personal care products such as creams or soap products.Type: ApplicationFiled: February 9, 2009Publication date: July 9, 2009Inventors: Shanta Modak, Nayana Baiju, Lauserpina Caraos
-
Publication number: 20090169653Abstract: The present invention relates to a composition for prophylaxis or treatment of urinary system infection, comprising a matrix metalloproteinase inhibitor. The present invention also relates to a method for prophylaxis or treatment of urinary system infection, comprising administering to a patient in need of such treatment an effective amount of composition comprising a matrix metalloproteinase inhibitor.Type: ApplicationFiled: March 10, 2009Publication date: July 2, 2009Inventor: Chih-Hsiung Lin
-
Publication number: 20090155393Abstract: A method for increasing the longevity of an old animal comprising administering to the animal a composition comprising one or more antioxidants in a total antioxidant amount sufficient to increase the longevity of the animal.Type: ApplicationFiled: July 14, 2006Publication date: June 18, 2009Inventors: Steven Curtis Zicker, Karen Joy Wedekind
-
Patent number: 7544668Abstract: Two hitherto unreported novel triterpene saponins were isolated in substantially pure form from the root of Ilex pubescens. The chemical structures and some properties of the triterpene saponin fraction have been elucidated to possess anti-inflammatory and analgesic activity. These two novel triterpene saponins and the triterpene saponin fraction may be used as pharmaceutical compositions in humans and mammals in need of such treatment.Type: GrantFiled: November 17, 2006Date of Patent: June 9, 2009Assignee: Hong Kong Baptist UniversityInventors: Liang Liu, Jing Rong Wang, Hua Zhou, Zhi Hong Jiang
-
Publication number: 20090136601Abstract: Anti-itch formulations for canines comprised of natural homeopathic ingredients. The formulation includes a combination of oil extracts and other natural ingredients typically characterized as spices or food enhancers. The formulation can be applied to a canine as an itch deterrent in addition to secondary beneficial effects.Type: ApplicationFiled: December 9, 2008Publication date: May 28, 2009Inventor: CYNTHIA K. MORALES
-
Publication number: 20090123548Abstract: A device for administering aromatherapy to a subject and the method of using the device are disclosed. The device comprises an aromatherapy composition housed within a container. The container has at least one opening or aperture through which the subject may breathe in or inhale the aromatic and volatile components of the aromatherapy composition through the mouth and/or nose. The aromatherapy composition comprises a particulate component comprising one or more irregularly- or regularly-shaped particles, granules, beads or the like. In addition, the aromatherapy composition has a volatile component comprising an amount of an essential oil-containing composition. The volatile component is that portion of the essential oil-containing composition that is retained by the particulate component after contacting the particulate component with the essential oil-containing composition and removal of the portion that is not retained by the particulate component.Type: ApplicationFiled: October 22, 2007Publication date: May 14, 2009Inventor: Susan Reimer Tom
-
Patent number: 7524888Abstract: This invention provides compositions and methods useful for repelling target pests. The compositions comprise an amount of a monoterpenoid or sesquiterpenoid effective to repel a target pest from a target area, the monoterpenoid or sesquiterpenoid in combination with a carrier. In one embodiment, the monoterpenoid or sesquiterpenoid is from a biorational source, such as a plant volatile. In a particular embodiment, the plant volatile is a monoterpenoid, such as “nepetalactone” (or the individual nepetalactone isomers) derived from catnip (Nepeta cataria). In another embodiment, the plant volatile is any one or a combination of sesquiterpenoids derived from the fruit of the Osage orange tree (Maclura pomifera). Such compositions have repellency against arthropods, such as cockroaches, mosquitoes, mites, ticks, spiders, and so forth.Type: GrantFiled: December 18, 2002Date of Patent: April 28, 2009Assignee: Iowa State University Research Foundation, Inc.Inventors: Joel R. Coats, Christopher J. Peterson, Junwei Zhu, Thomas C. Baker, Leah T. Nemetz
-
Patent number: 7514102Abstract: The Federal EPA has consistently limited the use of known toxicants (insecticides) to preclude their admixture into paints and coatings by contractors or homeowners for the purpose of repelling or killing insects on the dried or cured coating. The current invention is a method to repel rather than kill insects, arachnids, and other arthropods utilizing materials taken from the EPA's GRAS (Generally Recognized as Safe) List, obviating onerous Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) regulations and greatly extends the useful life of the insect-repellant materials by binding them into the dried film solids—greatly slowing their evaporation and degradation and creating a timed release of insect repellant material. Furthermore, the current invention utilizes the insect repellant nature of these materials to repel insects from the surrounding area during coating application, thereby eliminating the need for applying insect repellants such as DEET to the skin.Type: GrantFiled: April 25, 2006Date of Patent: April 7, 2009Assignee: CTA Products Group, Inc.Inventor: Gregg R. Overman
-
Patent number: 7514105Abstract: The present invention relates to a bioenhancing/bioavailability-facilitating composition comprising: an effective amount of an extract and/or at least one bioactive fraction from Cuminum cyminum; one or more additive selected from drugs, nutrients, vitamins, nutraceuticals, herbal drugs/products, micro nutrients, antioxidants along with pharmaceuticaly acceptable additives/excipient, and optionally, an effective amount of piperine or extract/fraction of piper nigrum or piper longum; and a process for the preparation of such extracts and active fractions from plant Cuminum cyminum.Type: GrantFiled: February 23, 2006Date of Patent: April 7, 2009Assignee: Council of Scientific and Industrial ResearchInventors: Ghulam Nabi Qazi, Kasturi Lal Bedi, Rakesh Kamal Johri, Manoj Kumar Tikoo, Ashok Kumar Tikoo, Subhash Chander Sharma, Sheikh Tasaduq Abdullah, Om Parkash Suri, Bishan Datt Gupta, Krishan Avtar Suri, Naresh Kumar Satti, Ravi Kant Khajuria, Surjit Singh, Anamika Khajuria, Bal Krishan Kapahi
-
Publication number: 20090081291Abstract: Aspects of the invention include a sustained release dosage form that can be administered to an oral cavity, e.g., the mouth. In certain embodiments, the sustained release dosage form is formulated as a lozenge or gum that may be administered to an oral cavity of a user for the purpose of dissolving over a prolonged period of time and thereby delivering an essential oil component therein. In certain embodiments, the sustained release dosage form includes a beneficial agent and, therefore, not only provides for the prolonged delivery of an essential oil component to an oral cavity, but also provides for the sustained release of a beneficial agent thereto. In certain embodiments, the sustained release dosage form includes a biocompatible, water-insoluble polymer, e.g.Type: ApplicationFiled: September 26, 2007Publication date: March 26, 2009Inventors: Jerry B. Gin, Benjamin F. Ross
-
Publication number: 20090081294Abstract: Aspects of the invention include a sustained release dosage form that can be administered to an oral cavity, e.g., the mouth. In certain embodiments, the sustained release dosage form is formulated as a lozenge or gum that may be administered to an oral cavity for the purpose of providing lubrication therein. In certain embodiments, the sustained release dosage form not only provides lubrication to a mucosal surface of an oral cavity, but also provides for the sustained release of a flavoring and/or beneficial agent. Accordingly, in certain embodiments, the sustained release dosage form includes a water-insoluble polymer, e.g., ethylcellulose, an essential oil component, and an effective amount of a film forming binder, e.g., xanthan gum.Type: ApplicationFiled: September 26, 2007Publication date: March 26, 2009Inventors: Jerry B. Gin, Benjamin F. Ross
-
Publication number: 20090068296Abstract: This invention relates to products and methods for improving sensory qualities of meat obtained from livestock. In particular, this invention relates to products and methods for reducing off-odors and off-tastes in meat from uncastrated male pigs (boar taint) or from other livestock fed on pasture. According to the invention, this is obtained by administering a product that contains an inducer of the constitutive androstane receptor (CAR). These include plant products derived from Artemisia spp, Citrus spp., Gingko biloba, Tagetes lucida, as well as vitamin E (alpha tocopherol). The CAR-inducer products of the invention may be used to reduce boar taint and thereby eliminate the need for castration of male pigs.Type: ApplicationFiled: February 22, 2007Publication date: March 12, 2009Inventor: Douglas L. Greger
-
Publication number: 20090041873Abstract: This invention provides a process for extracting a pharmaceutically active fraction from the foliage (leaves and stems) and/or roots of Rauvolfia vomitoria and the fruit of Citrus aurantium. In one aspect, the process requires extracting from a boiled tea of Rauvolfia vomitoria foliage and/or roots and Citrus aurantium fruit an active fraction made by filtering the boiled tea and concentrating the supernatant. In one embodiment, the fraction is concentrated by freeze drying the supernatant. The fraction is useful to treat a disorder associated with abnormally elevated glucose levels in a subject by administering to the subject a therapeutically effective amount of the extract or a pharmaceutical composition containing the extract. Such conditions include, but are not limited to the diabetes Type II, abnormal steraroyl-CoA desaturase activity, hyperphagia, abnormal lipid mobilization, abnormal fatty acid profile from the eye of the subject, ulcers and a glucosuria.Type: ApplicationFiled: September 29, 2008Publication date: February 12, 2009Inventor: Joan CAMPBELL-TOFTE
-
Publication number: 20090035391Abstract: A nasal irrigation solution comprising is disclosed comprising water and hydrastine extracted from one or more plants. Another solution comprises water and berberine extracted from one or more plants. These solutions are provided from an extract of goldenseal plant. Solutions are also disclosed having canadine, canadaline, and hydrastidine, all extracted from the goldenseal plant. More general solutions are disclosed including alkaloids extracted from one or more plants. The alkaloids are selected from one or more of the group consisting of: berberine, oxyberberine, berbamine, palmatine, magnoflorine, phellodendrine, jateorrhizine, candicine, menisperine, coptisine, worenine, columbamine, epiberberine, hydrastine, canadine, canadaline, hydrastidine, oxycyanthine, berberrubine, and isotetrandine. Alkaloids are provided from plant from the group consisting of: Oregon grape root, yellow root, phellodendron bark, coptis rhizome, barberry root, and Indian barberry root bark.Type: ApplicationFiled: August 12, 2008Publication date: February 5, 2009Inventors: Rajmani Tigunait, James L. Miles
-
Patent number: 7485259Abstract: A new, novel and useful disinfection and purification system comprised of organic compounds in synergistic action with selected metal ions and method of manufacture and use. One of the benefits that is derived from this system is the ability to quickly and easily treat a surface, fluid or medium for disinfection of bacteria, fungi, viruses, algae and protozoans, with a non-toxic, non-chlorinated mixture that effectively kills all such organisms in minutes or hours. The disinfection and purification system remains effective for long periods of time maintaining its disinfection capacity making it highly effective for stored or transported mediums such as potable drinking water. The disinfection and purification system may be incorporated with carbon block or membrane filters to disinfect filtered liquids such as water to render it potable.Type: GrantFiled: October 6, 2003Date of Patent: February 3, 2009Inventor: Bradley J. Eldred
-
Publication number: 20090022823Abstract: The present invention relates, in part, to the discovery that parenterally administered extended release formulations possess an unexpected advantage in treating patients possessing active CYP 3A4. This advantage is particularly beneficial where the individual is concomitantly administering a CYP 3A4 inhibitor or is in risk of doing so. Thus, the invention relates to a method for treating individuals possessing a functional CYP3A4 gene with an active agent metabolized by CYP3A4 comprising parenterally administering the active agent in a first extended release formulation in a first administration and the formulations for use in such methods. The invention further includes a method for preventing adverse drug reactions in individuals possessing a functional CYP3A4 gene with an active agent metabolized by CYP3A4 comprising parenterally administering the active agent in a first extended release formulation in a first administration.Type: ApplicationFiled: September 30, 2008Publication date: January 22, 2009Applicant: Alkermes, Inc.Inventors: Elliot Ehrich, Trevor Mundel
-
Patent number: 7479292Abstract: The method for making a hair pomade composition includes the steps of melting petroleum jelly over a heated surface and then mixing sesame seed oil, meadowfoam seed oil, pumpkin seed oil, Cyprus oil, basil sweet oil, Rosemary oil, black pepper oil, lemon oil, and Anise oil with the melted petroleum jelly into a mixture. Thereafter, the all-natural hair pomade mixture is solidified.Type: GrantFiled: April 3, 2008Date of Patent: January 20, 2009Inventor: Dixie Robinson
-
Publication number: 20090011042Abstract: An antimicrobial and antiviral barrier composition for topical application to the proximal anterior nares includes an antiseptic solution in combination with cocos nucifera (coconut oil) and one or more citrus oils such as, for example, citrus sinensis (orange oil). Various embodiments may also include one or more of the following additional ingredients: lauric acid; d-limonene; soy oil; emu oil; grapefruit seed extract; glycine soja; simmondsia chimensis (Jojoba); aloe vera; and a preservative, such as sodium benzoate, BHT, benzalkonium chloride, vitamin E.Type: ApplicationFiled: October 3, 2007Publication date: January 8, 2009Inventors: John A. Willimann, William Chandler
-
Publication number: 20090004303Abstract: Perfume ingredients and essential oils in synergistic combinations improve well-being by down-regulating arousal. This could lead to enhanced quality of life and reduced stress. The perfume compositions of the invention comprise one or more materials from each of the following groups: Group A: the essential oils lavender, lavandin, bergamot, chamomile, clary sage; Group B: 2-phenoxyethanol, 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone, benzophenone, cyclopentadecanolide, alpha-ionone, beta-ionone, para-methylacetophenone, [4-isopropylcyclohexyl]methanol. The ratio of the weight percentage based on the composition of group A materials to Group B materials lies within the range 1:9 to 9:1.Type: ApplicationFiled: March 17, 2006Publication date: January 1, 2009Inventors: Keith Douglas Perring, John Martin Behan, David Jonathan Bradshaw, Briony Care
-
Publication number: 20090004304Abstract: The present invention provides a powder superior in water-dispersibility/solubility, workability and tabletability, which contains an oil component containing a bioactive substance, a water-soluble polymer, a saccharide other than polysaccharides and a surfactant, at a particular ratio. The powder can be utilized for food, food with nutrient function claims, food for specified health uses, nutritional supplement, nutritional product, animal drug, drinks, feed, pharmaceutical product, quasi-drug, cosmetic and the like.Type: ApplicationFiled: June 23, 2008Publication date: January 1, 2009Applicant: Kaneka CorporationInventors: Toshinori Ikehara, Takayuki Sakogawa
-
Publication number: 20090004305Abstract: An antimicrobial and antiviral barrier composition for topical application to the proximal anterior nares includes an antiseptic solution in combination with Cocos nucifera (coconut oil) and one or more citrus oils such as, for example, Citrus sinensis (orange oil). Various embodiments may also include one or more of the following additional ingredients: lauric acid; d-limonene; soy oil; emu oil; grapefruit seed extract; glycine soja; aloe vera and a preservative, such as sodium benzoate.Type: ApplicationFiled: April 23, 2008Publication date: January 1, 2009Inventor: William Chandler
-
Publication number: 20080317884Abstract: A method to enhance disease resistance in an animal comprising feeding the animal a diet enriched in antioxidants and providing behavioral enrichment. In one embodiment, the behavioral enrichment comprises exercising the animal regularly effective to cause behavioral enrichment, wherein the feeding and exercising combination is effective to increase neutrophil phagocytosis and B cell percentages.Type: ApplicationFiled: June 22, 2007Publication date: December 25, 2008Inventors: Dennis E. Jewell, Steven C. Zicker
-
Publication number: 20080305135Abstract: A method of repelling wasps, which method comprises using a preparation comprising (a) one or more of ethyl 3-(N-n-butyl-N-acetylamino)propionate, dihydronepetalactone, and extract of catmint, and (b) at least one compound selected from certain perfume ingredients. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.Type: ApplicationFiled: May 14, 2008Publication date: December 11, 2008Applicant: Beiersdorf AGInventors: Rainer Kroepke, Jens Schulz, Jens Nielsen, Stephanie Von Der Fecht
-
Publication number: 20080305096Abstract: A method of providing controlled release of a biologically active substance within a subject's digestive system. The biologically active substance is administered concurrently with one or more soluble fibers in an oral dosage unit. The soluble fibers interact with the biologically active substance within the subject's digestive system to moderate and control the release of the biologically active substances in the subject's bloodstream. This provides more constant blood concentrations of the biologically active substances. The amount of soluble fibers in the oral dosage unit is greater than 40% by weight, and in some cases greater than 50% by weight of the oral dosage unit. The oral dosage unit typically contains from about 1 to 15g of soluble fiber, and in some cases from about 3 to 5g of soluble fiber. The biologically active substance may contain phytonutrients that promote the subject's cardiovascular system, immune system, or weight management.Type: ApplicationFiled: June 7, 2007Publication date: December 11, 2008Applicant: UNICITY INTERNATIONAL, INC.Inventors: Peter J. E. Verdegem, Stewart F. Hughes, Curtis A. Hedges, G. Paulo Bangerter
-
Publication number: 20080299103Abstract: Well-preserved aqueous topical compositions that satisfy one or more widely recognized organic certification standards. The compositions comprise a preservative system comprising an in situ hypoiodite generator; and a plant extract blend; optionally, an essential oil blend. Such compositions do not require synthetic preservatives, especially parabens. Suitable aqueous compositions may contain an oil phase, such as oil-in-water or water-in-oil emulsions.Type: ApplicationFiled: June 1, 2007Publication date: December 4, 2008Inventors: Liliana George, Steve Schnittger, Kathy Kretzschmar, Charles Craig Tadlock, Monica Apostol
-
Publication number: 20080292693Abstract: The present disclosure provides for a novel composition, with active ingredients comprising d-Limonene and Aloe mucilaginous polysaccharides (AMPs), for the treatment of a wide variety of digestive system disorders and diseases, including conditions which affect the stomach, esophagus, bowel, colon, liver or pancreas are considered digestive system diseases and disorders, including, but not limited to, gastro-esophagus reflux disease (GERD), digestive problems such as acid reflux disease, Crohn's disease, colitis, inflammatory bowel disease (IBD), irritable bowel disease (IBS), diverticulitis, gastritis, peptic ulcers and spastic colon.Type: ApplicationFiled: May 21, 2007Publication date: November 27, 2008Inventor: Scott F. Sones
-
Publication number: 20080292584Abstract: Disclosed herein are methods of using metaxalone. In one embodiment, the method comprises determining that a patient in need metaxalone therapy is taking a substance that is a n inhibitor or an inducer of a cytochrome p450 isozyme, wherein the cytochrome P450 is CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4, and adjusting administration to the patient of metaxalone or the substance to avoid an adverse event associated with metaxalone. In another embodiment, the method comprises informing a user that metaxalone ais metabolized by a cytochrome p450 isozyme, wherein the cytochrome P450 is CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4. Also included are articles of manufacture comprising a container containing a dosage form of metaxalone, wherein the container is associated with published material informing that metaxalone affects activity of a cytochrome p450 isozyme. Also disclosed are a method of treatment and a method of manufacturing a metaxalone product.Type: ApplicationFiled: May 28, 2008Publication date: November 27, 2008Applicant: MUTUAL PHARMACEUTICAL COMPANY, INC.Inventors: Richard H. Roberts, Jie Du, Matthew W. Davis
-
Publication number: 20080292607Abstract: This invention describes a comprehensive nutraceutical designed to antagonize major mitigating factors to the degenerative process associated with Parkinson's disease. The formulation is comprised of a primary base of pyruvate, succinate and/or oxaloacetate, fruit extracts and anthocyanins, further combined with specific macro/micronutrients, trace elements, amino acids, flavonoids and concentrated plant sources. The nutraceutical contains substances that should attenuate the loss of ATP/toxicity by PD model toxins: 1-methyl-4-phenylpyridinium and rotenone, scavenge hydrogen peroxide/O2.Type: ApplicationFiled: July 29, 2008Publication date: November 27, 2008Inventors: Elizabeth Mazzio, Karam Soliman
-
Publication number: 20080286254Abstract: A composition containing a licorice polyphenol and other active ingredient (antioxidant ingredient, polyphenol other than licorice polyphenol or a component relating to lipid absorption or metabolism) is highly safe, can be produced easily, and can be utilized for foods and drinks such as health food, food with health claims (specified health food, food with nutrient function claims) and the like, pharmaceutical products, quasi-drugs, cosmetics and the like. In addition, since the composition has a body fat accumulation suppressing effect, a body fat decomposition promoting effect or energy production promoting effect, it is useful for the treatment of obesity, metabolic syndrome and the like.Type: ApplicationFiled: May 16, 2008Publication date: November 20, 2008Applicant: Kaneka CorporationInventors: Hirokazu Sakamoto, Yuji Tominaga, Shiro Kitamura, Shinichi Yokota
-
Publication number: 20080268038Abstract: Provided are compositions and methods for increasing diet induced thermogenesis. Typically, the compositions are comprised of L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-valine and L-threonine.Type: ApplicationFiled: April 25, 2008Publication date: October 30, 2008Inventor: Robert R. Wolfe
-
Publication number: 20080260869Abstract: Disclosed is a composition comprising at least two of the following ingredients: Magnolia extract, honokiol, humulus lupulus extract, hesperidin methyl chalcone, gotu kola, dipeptide valyl-tryptophane, palmitoyl tetrapeptide-3, corylus avellana bud extract, centella asiatica extract, cucumis sativa extract, morus alba extract, hibiscus sabdariffa flower extract, vitis vinifera extract, ascorbyl glucoside, citrus medica limonum extract, avena sativa kernel extract, hydrolyzed soy protein, aniseed myrtle extract, tasmania lanceolata leaf extract, artemisia abrotanum extract, or citrus grandis fruit extract or any combination thereof. Also disclosed are methods of treating skin conditions by topically applying the composition to skin.Type: ApplicationFiled: March 14, 2008Publication date: October 23, 2008Applicant: Mary Kay Inc.Inventors: Jim Faller, David Gan, Michelle Hines, Lisa Mangos
-
Patent number: 7438936Abstract: A dietary supplement including a unique combination of fruits, vegetables, herbs, and optionally vitamins, minerals and specialty ingredients. The supplement can include a fruit ingredient, a vegetable ingredient and an herbal ingredient, wherein the fruit ingredient is at least one of pomegranate and citrus bioflavonoids, wherein the vegetable ingredient is at least one of asparagus, lutein, lycopene and watercress, and wherein the herbal ingredient is at least one of basil, oregano and rosemary. The supplement can be administered to subjects to reduce risk factors in a subject, for example, by lowering homocysteine levels and/or reducing DNA damage. The supplement can increase plasma levels of at least one of vitamin B6, Vitamin B12, folate, and beta-carotene and other vitamins or substances in the subject.Type: GrantFiled: February 27, 2006Date of Patent: October 21, 2008Assignee: Access Business Group International LLCInventors: Ruo G. Huang, Audra J. Davies, Aaron W. Crawford, Edward S. Kahler, Donald J. Pusateri, Stephen R. Missler
-
Publication number: 20080254153Abstract: The invention pertains to a water dispersible, preferably a powder composition of water extractible bioactive components of exclusively fruit or vegetable or plant origin. These components are obtainable by: a) subjecting a selected fruit or vegetable or plant material to homogenisation in weak alkaline conditions and at moderate temperature; b) separating the liquid extract from the homogenised mass and subsequently bringing it to neutrality; and c) eventually concentrating or drying, preferably by freeze drying, the neutralized liquid extract. The composition can be used as primary composition in the preparation of a food product for oral administration, a food supplement, a pet food product, a pet food supplement, a cosmetic preparation or a pharmaceutical preparation.Type: ApplicationFiled: September 19, 2006Publication date: October 16, 2008Inventors: Junkuan Wang, Raymond Bertholet, Pierre Ducret
-
Publication number: 20080241289Abstract: Disclosed herein are non-nucleoside reverse transcriptase inhibitors having structural Formula I, processes of preparation thereof, pharmaceutical compositions thereof, and the methods of their use thereof.Type: ApplicationFiled: February 22, 2008Publication date: October 2, 2008Applicant: AUSPEX PHARMACEUTICALS, INC.Inventors: Thomas G. Gant, Sepehr Sarshar
-
Patent number: 7429395Abstract: This invention provides a process for extracting a pharmaceutically active fraction from the foliage (leaves and stems) and/or roots of Rauvolfia vomitoria and the fruit of Citrus aurantium. In one aspect, the process requires extracting from a boiled tea of Rauvolfia vomitoria foliage and/or roots and Citrus aurantium fruit an active fraction made by filtering the boiled tea and concentrating the supernatant. In one embodiment, the fraction is concentrated by freeze drying the supernatant. The fraction is useful to treat a disorder associated with abnormally elevated glucose levels in a subject by administering to the subject a therapeutically effective amount of the extract or a pharmaceutical composition containing the extract. Such conditions include, but are not limited to the diabetes Type II, abnormal steraroyl-CoA desaturase activity, hyperphagia, abnormal lipid mobilization, abnormal fatty acid profile from the eye of the subject, ulcers and a glucosuria.Type: GrantFiled: October 26, 2005Date of Patent: September 30, 2008Inventor: Joan Campbell-Tofte
-
Publication number: 20080233219Abstract: The present invention provides a composition for diet comprising an essential oil adsorbent is coated with neroli oil to prepare an essential oil-coated particle, and then the particle is covered with a essential oil adsorbing and desorbing agent to prepare the carbon-coated particle (NR), the carbon-coated particle similarly prepared by using jasmin oil instead of neroli oil (JS), the carbon-coated particle similarly prepared by using rose oil instead of neroli oil (RO), and/or the carbon-coated particle similarly prepared by using cineol type Eucalyptus oil instead of neroli oil (CE), and the agent for diet comprising thereof as active ingredients. Accordingly, the agent for treating adipositas having high safety, of which composition ratio can be changed depending on a symptom of adipositas, is provided.Type: ApplicationFiled: February 27, 2008Publication date: September 25, 2008Applicant: NATURE TECHNOLOGY INC.Inventor: Takeshi Karita
-
Publication number: 20080220035Abstract: A composition for deterring a domestic pet from intruding upon a designated area. The composition includes a citrus oil, foaming and wetting agents in an aqueous carrier. The composition is particularly effective when applied in the form of a mist or spray deterring a cat from scratching furniture or related items.Type: ApplicationFiled: March 9, 2007Publication date: September 11, 2008Inventor: Erwin del Pinal
-
Patent number: 7416750Abstract: A Composition to provide nutritional support for mammals having glycemic control and deficit concerns, and assist in managing glycemic controls deficits, with a synergistic combination of natural ingredients.Type: GrantFiled: February 26, 2007Date of Patent: August 26, 2008Assignee: NBTY, Inc.Inventors: Angelica Vrablic, Glenn Schneider, Robert Silverman
-
Patent number: 7416749Abstract: A dietary supplement including a unique combination of fruits, vegetables, herbs, and optionally vitamins, minerals and specialty ingredients. The supplement can include a fruit ingredient, a vegetable ingredient and an herbal ingredient, wherein the fruit ingredient is at least one of pomegranate and citrus bioflavonoids, wherein the vegetable ingredient is at least one of asparagus, lutein, lycopene and watercress, and wherein the herbal ingredient is at least one of basil, oregano and rosemary. The supplement can be administered to subjects to correct a dietary deficiency of phytochemicals and other nutrients, improve the amount of antioxidants in the subject, and decrease free radical damage in the subject.Type: GrantFiled: August 11, 2004Date of Patent: August 26, 2008Assignee: Access Business Group International LLCInventors: Ruo Huang, Audra J. Davies, Aaron W. Crawford, Edward S. Kahler, Donald J. Pusateri, Stephen R. Missler
-
Publication number: 20080193387Abstract: Essential-oil compositions comprising Lippia javanica essential oil in combination with one, two, three, four, five, six or more essential oils are provided. The Lippia javanica essential-oil compositions are effective for killing and/or repelling ectoparasites and/or pests, including lice, ticks, mosquitoes, mites, ants and fleas. Methods of using the compositions comprising Lippia javanica essential oil in combination with one, two, three, four, five, six or more essential oils for killing or repelling ectoparasites and/or pests also are provided. Also provided are articles of manufacture and kits that include the Lippia javanica essential-oil compositions.Type: ApplicationFiled: February 14, 2007Publication date: August 14, 2008Inventor: RICKI DE WOLFF
-
Publication number: 20080181975Abstract: This invention provides a vasoprotective agent containing a plant or its extract as an effective ingredient. The plant is selected from the group consisting of rosemary, sage, geranium herb, adlai, field horsetail, bitter orange peel, fucus, burdock, dokudami, Japan pepper, Ophiopogon tuber, ginkgo, natsume and dishcloth gourd.Type: ApplicationFiled: January 31, 2007Publication date: July 31, 2008Applicant: Kao CorporationInventors: Naonobu Yoshizuka, Yuko Fukuda, Yasuko Amano, Minoru Takizawa, Hajime Soga, Shinobu Mori, Akira Hachiya
-
Publication number: 20080175928Abstract: The disclosure herein is directed to organic skin-based products that comprise an excess of 70% organic ingredients. The skin care products described herein are composed of a plurality of organic juices and other organic materials.Type: ApplicationFiled: November 1, 2007Publication date: July 24, 2008Applicant: JUICE BEAUTYInventors: Melissa Jochim, Karen Behnke
-
Publication number: 20080175879Abstract: There is provided a covering for laying over the top of any eating, drinking or sleeping surface, or a table cloth or a table cover substantially less visible, if not invisible to, and capable of, repelling insects and animals. The covering is opaque and bears a color that is outside the vision spectrum of animals and insects. It comprises a synthetic resin, a non-toxic dye and all natural insect and animal repellent mixture. The all natural insect and animal repellent mixture further comprises peppermint oil, lemon oil, citronella oil, rosemary oil, clove oil and geranium oil. In the preferred embodiment the all natural, insect and animal repellent mixture comprises 15% peppermint oil, 10% lemon oil, 4% citronella oil, 5% rosemary oil, 3% clove oil and 3% geranium oil.Type: ApplicationFiled: January 23, 2007Publication date: July 24, 2008Inventor: Terry M. Feinberg
-
Publication number: 20080166426Abstract: A composition and method of treatment for the Staphylococci, Streptococci, and Enterococcus faecalis Family of infections and their associated symptoms using Sangre de Grado (“SDG”). SDG is extracted from the lechleri Croton tree. SDG is formulated and administered to treat the Staphylococci, Streptococci, and Enterococcus faecalis Family of infections and their associated symptoms. SDG is effective against these various bacterial infections including the often deadly MRSA.Type: ApplicationFiled: January 30, 2008Publication date: July 10, 2008Inventor: Gary Pekoe
-
Publication number: 20080166436Abstract: Otitis externa is a condition of the outer ear canal in mammalian animals, especially dogs and cats, marked by inflammation and infection of tissue, buildup of ear wax, and draining of ear exudate. Symptoms of infection are, among others, excessive cerumen, alopecia in the ear flap, crusts, and ear pruritis. Typical causes of otitis externa are fungi, bacteria, and mites. A medicating mixture in accordance with the invention, comprising cold-pressed citrus oil, deionized water, and, optionally, hydrolysates of milk proteins, when applied topically to an infected ear canal can produce significant reduction in symptoms. In a clinical study, 95% of an infected population of dogs were normalized without other or further treatment.Type: ApplicationFiled: January 10, 2007Publication date: July 10, 2008Applicant: Apperon Inc.Inventor: Gary Pusillo
-
Publication number: 20080166437Abstract: Methods for reducing pests (e.g., nematodes, oomycetes, fungi, viruses) in an object or area by applying to the object or area a pest reducing effective amount of a composition containing hydrogen peroxide, orange terpene oil, orange valencia oil, at least one non-ionic emulsifier, distilled water or deionized water, and optionally hydrogen peroxide. Methods for treating gastrointestinal nematode infection in ruminant animals by administering to a ruminant animal in need of such treatment a therapeutically effective amount of a composition containing orange terpene oil, orange valencia oil, at least one non-ionic emulsifier, distilled water or deionized water, and optionally hydrogen peroxide.Type: ApplicationFiled: January 3, 2008Publication date: July 10, 2008Inventors: Erin N. Rosskopf, Leonard L. Therrien, Scott T. Adkins, Fanny Iriarte, Joyce G. Foster, Nancy Kokalis-Burelle
-
Publication number: 20080160000Abstract: There is provided an animal feed, an anticoccidial agent, and an anticlostridial agent having less harm and an excellent prophylactic and/or therapeutic effect for coccidiosis and clostridial disease. Also provided is a prophylactic and/or therapeutic feed for coccidiosis containing pinene, thymol, eugenol, and limonene; an anticoccidial agent containing pinene, thymol, eugenol, and limonene as active ingredients; a clostridial disease prophylactic and/or therapeutic feed containing pinene, thymol, eugenol, and limonene; and an anticlostridial agent containing pinene, thymol, eugenol, and limonene as active ingredients.Type: ApplicationFiled: October 25, 2007Publication date: July 3, 2008Applicant: Marubeni Nisshin Feed Co., Ltd.Inventors: Yukihiro Motozono, Hiroyuki Suzuki, Kazuhiro Hatano, Masaaki Kise, Shinichi Horigome, Katsuhiro Mori, Yoshinaga Doi, Ryoji Koga
-
Publication number: 20080121361Abstract: A method for making an animal bedding fiber product, the method includes providing fiber from paper sludge, formulating the fiber in a mixture including a first desiccant agent including ash, so as to form a friable aggregate. Further, a fiber product including at least one short paper fiber from a secondary fiber, one or more inorganic fillers including kaolin clay; and a first desiccant agent including ash. Further still, a heatless process for making a fiber product including providing fiber from paper sludge, formulating the fiber in a non-active heat generating mixture including a first desiccant agent including ash, so as to form a waste fiber product.Type: ApplicationFiled: August 17, 2006Publication date: May 29, 2008Inventor: Patrick Kennedy